Haemonetics
197 hedge funds and large institutions have $2.11B invested in Haemonetics in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 79 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
19% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 79
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $486K
Holders
197
Holding in Top 10
3
Calls
–
Puts
$486K
Top Buyers
| 1 | +$46.2M | |
| 2 | +$20.9M | |
| 3 | +$17M | |
| 4 |
Millennium Management
New York
|
+$14.1M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$9.73M |
Top Sellers
| 1 | -$37.2M | |
| 2 | -$24.3M | |
| 3 | -$10.7M | |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$10.4M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$8.66M |